Skip to main content
Regulation - Fall 2024 - Cover

Fall 2024

Vol. 47 No. 3
From the Cover

Are Drug Prices Abroad Too Low?

By H.E. Frech III, Mark Pauly, and William S. Comanor

Countries’ contributions to the pharmaceutical R&D public good reflect the size of their economies.

Behind the Issue

Unintended Consequences

The Podcast of Regulation
In This Episode

There is substantial overlap between the Biden and Trump administrations on economic policy. Both presidents have favored protectionist industrial policy and higher import tariffs. Yet these policies would not only fail to return America to the economy of the early 20th century; they would harm most ordinary American workers and consumers in the attempt. In this episode, Peter and Paul discuss the incredible cost of Trump’s proposed tariff increases, the retrograde nature of Biden’s approach to the steel industry, and a surprising result from the research on universal basic income.

Features
What Happens Post-Chevron?

Whither Congress?

By Keith B. Belton

Aside from creating uncertainty, Loper Bright will likely increase the number of judicial challenges as well as judicial invalidation of rules.

Short-Term vs. Long-Term Effects

By Stuart Shapiro

As the bureaucratic literature often observes, mission is very important in the motivational structure of public servants.

What’s Next after Loper Bright?

By Thomas J. Kniesner and W. Kip Viscusi

The regulatory problems that emerged both before and after the Chevron decision are much more fundamental and can be traced back to the authorizing statutes, not just the behavior of the administrative state.

Briefly Noted
Final Word
The Weirdness of Politics
By Tim Rowland

Last month, Democrats trotted out a word to chastise this sort of policy flimflam: “Weird.”